146 related articles for article (PubMed ID: 11583144)
1. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins.
Sanders CR; Ismail-Beigi F; McEnery MW
Biochemistry; 2001 Aug; 40(32):9453-9. PubMed ID: 11583144
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
3. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
4. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
[TBL] [Abstract][Full Text] [Related]
5. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction.
Tobler AR; Notterpek L; Naef R; Taylor V; Suter U; Shooter EM
J Neurosci; 1999 Mar; 19(6):2027-36. PubMed ID: 10066256
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22.
Marinko JT; Wright MT; Schlebach JP; Clowes KR; Heintzman DR; Plate L; Sanders CR
J Biol Chem; 2021; 296():100719. PubMed ID: 33933451
[TBL] [Abstract][Full Text] [Related]
7. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth disease.
Sakakura M; Hadziselimovic A; Wang Z; Schey KL; Sanders CR
Structure; 2011 Aug; 19(8):1160-9. PubMed ID: 21827951
[TBL] [Abstract][Full Text] [Related]
9. Conformational Stability and Pathogenic Misfolding of the Integral Membrane Protein PMP22.
Schlebach JP; Narayan M; Alford C; Mittendorf KF; Carter BD; Li J; Sanders CR
J Am Chem Soc; 2015 Jul; 137(27):8758-68. PubMed ID: 26102530
[TBL] [Abstract][Full Text] [Related]
10. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
11. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
Müller HW
Glia; 2000 Jan; 29(2):182-5. PubMed ID: 10625337
[TBL] [Abstract][Full Text] [Related]
12. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.
Fontanini A; Chies R; Snapp EL; Ferrarini M; Fabrizi GM; Brancolini C
J Biol Chem; 2005 Jan; 280(3):2378-87. PubMed ID: 15537650
[TBL] [Abstract][Full Text] [Related]
13. Peripheral myelin protein 22 alters membrane architecture.
Mittendorf KF; Marinko JT; Hampton CM; Ke Z; Hadziselimovic A; Schlebach JP; Law CL; Li J; Wright ER; Sanders CR; Ohi MD
Sci Adv; 2017 Jul; 3(7):e1700220. PubMed ID: 28695207
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
15. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
17. A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease.
Li LX; Dong HL; Xiao BG; Wu ZY
Chin Med J (Engl); 2017 Aug; 130(15):1779-1784. PubMed ID: 28748849
[TBL] [Abstract][Full Text] [Related]
18. Peripheral myelin protein 22 preferentially partitions into ordered phase membrane domains.
Marinko JT; Kenworthy AK; Sanders CR
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14168-14177. PubMed ID: 32513719
[TBL] [Abstract][Full Text] [Related]
19. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
20. The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized.
Myers JK; Mobley CK; Sanders CR
Biochemistry; 2008 Oct; 47(40):10620-9. PubMed ID: 18795802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
